Reuters logo
BRIEF-Insys Therapeutics files new drug application for buprenorphine sublingual spray
September 29, 2017 / 1:38 PM / in 19 days

BRIEF-Insys Therapeutics files new drug application for buprenorphine sublingual spray

Sept 29 (Reuters) - Insys Therapeutics Inc

* Insys Therapeutics files new drug application (NDA) for buprenorphine sublingual spray with FDA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below